Sharun Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.39 Cr
- Satisfied Charges ₹ 10.80 Cr
- Revenue Growth -53.16%
- Profit Growth -69.44%
- Ebitda -27.29%
- Net Worth 3.73%
- Total Assets -8.65%
About Sharun Pharmaceuticals
Sharun Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 July 2016 (Eight years and six months 24 days old ). Its registered office is in Pondicherry, Pondicherry, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹10.39 Cr. The company has closed loans amounting to ₹10.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinodha Baskar and Rajeswari Krishnamoorthy serve as directors at the Company.
Company Details
-
Location
Pondicherry, Pondicherry, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33309PY2016PTC008082
-
Company No.
008082
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jul 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pondicherry
Industry
Who are the key members and board of directors at Sharun Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeswari Krishnamoorthy
|
Managing Director | 18-Jul-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vinodha Baskar
|
Director | 25-Nov-2022 | Current |
Financial Performance of Sharun Pharmaceuticals.
Sharun Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 53.16% decrease. The company also saw a substantial fall in profitability, with a 69.44% decrease in profit. The company's net worth moved up by a moderate rise of 3.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sharun Pharmaceuticals?
In 2023, Sharun Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vishwamithrha Life Sciences Private LimitedVinodha Baskar and Rajeswari Krishnamoorthy are mutual person
-
Vertex Pharma Chemicals Private Limited
Rajeswari Krishnamoorthy is a mutual person
Charges (Loans)
₹10.39 Cr
₹10.80 Cr
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 10.39 Cr
- City Union Bank Limited : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2022 | Indian Overseas Bank | ₹10.39 Cr | Open |
| 19 Apr 2022 | City Union Bank Limited | ₹8,000.00 | Open |
| 20 Aug 2016 | City Union Bank Limited | ₹10.80 Cr | Satisfied |
How Many Employees Work at Sharun Pharmaceuticals?
Unlock and access historical data on people associated with Sharun Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sharun Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sharun Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
